
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8530-8530
Open Access | Times Cited: 94
Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8530-8530
Open Access | Times Cited: 94
Showing 1-25 of 94 citing articles:
CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?
Chunxue Zhang, Yuxiang Fei, Hui Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 58
Chunxue Zhang, Yuxiang Fei, Hui Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 58
The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis
Teizo Yoshimura, Chunning Li, Yuze Wang, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 714-738
Open Access | Times Cited: 55
Teizo Yoshimura, Chunning Li, Yuze Wang, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 714-738
Open Access | Times Cited: 55
Role of chemokine systems in cancer and inflammatory diseases
Hongyi Li, Min Wu, Xia Zhao
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 62
Hongyi Li, Min Wu, Xia Zhao
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 62
CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling
Tao Xie, Du-Jiang Fu, Zhimin Li, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 61
Tao Xie, Du-Jiang Fu, Zhimin Li, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 61
Tumor−associated macrophage polarization in the inflammatory tumor microenvironment
Zijuan Zou, Hongfen Lin, Mengsen Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 41
Zijuan Zou, Hongfen Lin, Mengsen Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 41
The role of macrophages in the tumor microenvironment and tumor metabolism
Pritam Sadhukhan, Tanguy Y. Seiwert
Seminars in Immunopathology (2023) Vol. 45, Iss. 2, pp. 187-201
Closed Access | Times Cited: 28
Pritam Sadhukhan, Tanguy Y. Seiwert
Seminars in Immunopathology (2023) Vol. 45, Iss. 2, pp. 187-201
Closed Access | Times Cited: 28
Macrophages as Promising Carriers for Nanoparticle Delivery in Anticancer Therapy
Anna Wróblewska, Agnieszka Szczygieł, Bożena Szermer-Olearnik, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 4521-4539
Open Access | Times Cited: 25
Anna Wróblewska, Agnieszka Szczygieł, Bożena Szermer-Olearnik, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 4521-4539
Open Access | Times Cited: 25
Unveiling the Immune Microenvironment’s Role in Breast Cancer: A Glimpse into Promising Frontiers
Amalia Kotsifaki, Nektarios Alevizopoulos, Vassiliki Dimopoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15332-15332
Open Access | Times Cited: 23
Amalia Kotsifaki, Nektarios Alevizopoulos, Vassiliki Dimopoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15332-15332
Open Access | Times Cited: 23
Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer
Na Song, Kai Cui, Liqun Zeng, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176357-176357
Closed Access | Times Cited: 16
Na Song, Kai Cui, Liqun Zeng, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176357-176357
Closed Access | Times Cited: 16
The role of CCL2/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine
Sabina Pozzi, Ronit Satchi‐Fainaro
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115318-115318
Closed Access | Times Cited: 16
Sabina Pozzi, Ronit Satchi‐Fainaro
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115318-115318
Closed Access | Times Cited: 16
Patient-Specific Vascularized Tumor Model: Blocking TAM Recruitment with Multispecific Antibodies Targeting CCR2 and CSF-1R
Huu Tuan Nguyen, Ellen L. Kan, Mouhita Humayun, et al.
Biomaterials (2024) Vol. 312, pp. 122731-122731
Open Access | Times Cited: 11
Huu Tuan Nguyen, Ellen L. Kan, Mouhita Humayun, et al.
Biomaterials (2024) Vol. 312, pp. 122731-122731
Open Access | Times Cited: 11
Decoding the role of the CCL2/CCR2 axis in Alzheimer’s disease and innovating therapeutic approaches: Keeping All options open
Reyhaneh Arfaei, Narges Mikaeili, Fatemeh Daj, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112328-112328
Closed Access | Times Cited: 9
Reyhaneh Arfaei, Narges Mikaeili, Fatemeh Daj, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112328-112328
Closed Access | Times Cited: 9
Identification of SPP1+ macrophages in promoting cancer stemness via vitronectin and CCL15 signals crosstalk in liver cancer
Yizhou Wang, Qing Wang, Shuangfen Tao, et al.
Cancer Letters (2024) Vol. 604, pp. 217199-217199
Open Access | Times Cited: 9
Yizhou Wang, Qing Wang, Shuangfen Tao, et al.
Cancer Letters (2024) Vol. 604, pp. 217199-217199
Open Access | Times Cited: 9
The pleiotropic roles of adipocyte secretome in remodeling breast cancer
Xiaomei Zhou, Jun Zhang, Wenchang Lv, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 33
Xiaomei Zhou, Jun Zhang, Wenchang Lv, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 33
Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma
Lingbin Meng, Katharine A. Collier, Peng Wang, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 34-34
Open Access | Times Cited: 21
Lingbin Meng, Katharine A. Collier, Peng Wang, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 34-34
Open Access | Times Cited: 21
Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti–PD-1 resistance
Ashwin Ajith, Kenza Mamouni, Daniel D. Horuzsko, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 21
Open Access | Times Cited: 19
Ashwin Ajith, Kenza Mamouni, Daniel D. Horuzsko, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 21
Open Access | Times Cited: 19
Role of MCP-1/CCR2 axis in renal fibrosis: Mechanisms and therapeutic targeting
Shiyang He, Lan Yao, Jun Li
Medicine (2023) Vol. 102, Iss. 42, pp. e35613-e35613
Open Access | Times Cited: 19
Shiyang He, Lan Yao, Jun Li
Medicine (2023) Vol. 102, Iss. 42, pp. e35613-e35613
Open Access | Times Cited: 19
Do PFCAs drive the establishment of thyroid cancer microenvironment? Effects of C6O4, PFOA and PFHxA exposure in two models of human thyroid cells in primary culture
Francesca Coperchini, Alessia Greco, Laura Croce, et al.
Environment International (2024) Vol. 187, pp. 108717-108717
Open Access | Times Cited: 8
Francesca Coperchini, Alessia Greco, Laura Croce, et al.
Environment International (2024) Vol. 187, pp. 108717-108717
Open Access | Times Cited: 8
MRI Detection of Lymph Node Metastasis through Molecular Targeting of C–C Chemokine Receptor Type 2 and Monocyte Hitchhiking
Noah Trac, Zixi Chen, Hyun-seok Oh, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 2091-2104
Closed Access | Times Cited: 7
Noah Trac, Zixi Chen, Hyun-seok Oh, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 2091-2104
Closed Access | Times Cited: 7
Traversing through the Mechanistic Event Analysis in IL-6 and IL-17 Signaling for a New Therapeutic Paradigm in NSCLC
Riya Khilwani, Shailza Singh
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1216-1216
Open Access | Times Cited: 6
Riya Khilwani, Shailza Singh
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1216-1216
Open Access | Times Cited: 6
Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review)
Pengfei Su, Li Ou, Kun Ke, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 6
Open Access | Times Cited: 6
Pengfei Su, Li Ou, Kun Ke, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 6
Open Access | Times Cited: 6
Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?
Hongbin Wang, Mia C. Borlongan, Howard L. Kaufman, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 5, pp. e008025-e008025
Open Access | Times Cited: 6
Hongbin Wang, Mia C. Borlongan, Howard L. Kaufman, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 5, pp. e008025-e008025
Open Access | Times Cited: 6
Dendritic cell-derived exosomes (Dex): Underlying the role of exosomes derived from diverse DC subtypes in cancer pathogenesis
Gulixian Tuluwengjiang, Irodakhon Rasulova, Shamim Ahmed, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155097-155097
Closed Access | Times Cited: 5
Gulixian Tuluwengjiang, Irodakhon Rasulova, Shamim Ahmed, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155097-155097
Closed Access | Times Cited: 5
Molecular understanding and clinical aspects of tumor-associated macrophages in the immunotherapy of renal cell carcinoma
Han Liu, Zongwei Lv, Gong Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 5
Han Liu, Zongwei Lv, Gong Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 5
Development of a Novel Anti-Mouse CCR2 Monoclonal Antibody (C2Mab-6) by N-Terminal Peptide Immunization
Tomohiro Tanaka, Guanjie Li, Teizo Asano, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2022) Vol. 41, Iss. 2, pp. 80-86
Closed Access | Times Cited: 20
Tomohiro Tanaka, Guanjie Li, Teizo Asano, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2022) Vol. 41, Iss. 2, pp. 80-86
Closed Access | Times Cited: 20